March 2026
1. CHOI ES, Koo B, Kim S, Song IH, et al
   MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller.
   Radiology. 2026;318:e252611.
   

   >> Share

   
   
2. LI Y, Lu S, Mao S, Li Q, et al
   Contrast-Enhanced US Using Perfluorobutane for Diagnosing Small HCC in High-Risk Patients: Comparison with MRI LI-RADS Version 2018.
   Radiology. 2026;318:e252271.
   

   >> Share

   
   
3. KUHNEL C, Schmidt TN, Freesmeyer M, Schricke M, et al
   Transarterial Radioembolization: Medical Staff Dosimetry for (90)Y-Resin, (90)Y-Glass, and (166)Ho-PLLA Microspheres.
   Radiology. 2026;318:e251822.
   

   >> Share

   
   
4. DOPPELT G, Occean BV, Fabbro-Peray P, Haefliger L, et al
   The Safety Standards for Liver Percutaneous Thermal Ablation: A Meta-Analysis of Adverse Events over 15 Years.
   Radiology. 2026;318:e251517.
   

   >> Share

   
   
5. DIMOPOULOS MP, Sotirchos VS, Vakiani E, Sigel C, et al
   Optimizing Colorectal Liver Metastasis Ablation through Metabolic Imaging, Margin Assessment, and Biopsy (The OPTABLATE Prospective Trial).
   Radiology. 2026;318:e250864.
   

   >> Share

   
   
6. CENTNER CS, Choi R, Georgiades CS, Yarchoan M, et al
   Thermal and Nonthermal Liver Ablation: Mechanistic Foundations, Clinical Implementation, Immunologic Trial Design, and Artificial Intelligence.
   Radiology. 2026;318:e250263.
   

   >> Share

   
   
7. CHO SH, Jung YJ, Hong SB, Choi SJ, et al
   Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.
   Radiology. 2026;318:e252892.
   

   >> Share

   
   February 2026
8. QI BN, Zhao XY, Lv WJ, Shan S, et al
   Nodular Transformation-driven Circulatory Remodeling in Biliary Atresia-induced Pediatric Biliary Cirrhosis: A Three-dimensional Phase-Contrast CT Rendering.
   Radiology. 2026;318:e252332.
   

   >> Share

   
   
9. LEWIS S, Wildman-Tobriner B, Cuevas J, Calle S, et al
   Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis.
   Radiology. 2026;318:e251497.
   

   >> Share

   
   
10. KIM TH, Harding JJ, Chernyak V, Mendiratta-Lala M, et al
    How I Do It: Systemic Therapies for Primary Liver Cancers.
    Radiology. 2026;318:e251371.
    

    >> Share

    
    January 2026
11. GEORGIADES C
    Intrahepatic Cholangiocarcinoma: Local-Regional Therapies Join the Fight.
    Radiology. 2026;318:e253806.
    

    >> Share

    
    
12. CHEN S, Qi H, Shen L, Lin L, et al
    Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2026;318:e252521.
    

    >> Share

    
    
13. PANG C, Li J, An C, Wang Z, et al
    Survival Outcomes of Microwave Ablation Compared with Repeat Liver Resection in the Treatment of Recurrent Intrahepatic Cholangiocarcinoma.
    Radiology. 2026;318:e243254.
    

    >> Share

    
    
14. CHENG MQ, Hu HT, Wu SH, Huang H, et al
    Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance.
    Radiology. 2026;318:e252252.
    

    >> Share

    
    
15. DAGGUMATI L, Stark L, Booth AL, Fraum TJ, et al
    Case 344: Hepatic Epithelioid Hemangioendothelioma.
    Radiology. 2026;318:e251815.
    

    >> Share

    
    
16. MATTEINI F, Vilgrain V
    Isolated Hepatic Mucormycosis in Acute Lymphoblastic Leukemia.
    Radiology. 2026;318:e252306.
    

    >> Share

    
    December 2025
17. ZHU L, Jiang B, Fei X, Xu Y, et al
    Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy.
    Radiology. 2025;317:e251698.
    

    >> Share

    
    
18. XIAO Z, Liu X
    Hepatocellular Carcinoma Presenting as Bile Duct Tumor Thrombus without Obvious Intrahepatic Mass.
    Radiology. 2025;317:e251418.
    

    >> Share

    
    November 2025
19. YU SCH, Chan L, Lee KF, Cho CCM, et al
    Ethiodized Oil-based Transarterial Chemoembolization for Hepatocellular Carcinoma: Randomized Clinical Trial of Anhydrous Cisplatin Suspension versus Cisplatin Emulsion.
    Radiology. 2025;317:e242982.
    

    >> Share

    
    
20. PARK R, Choi ES, Byun JH, Won HJ, et al
    Diagnostic Value of Precontrast Low Attenuation as a LI-RADS CT Ancillary Feature for Hepatocellular Carcinoma.
    Radiology. 2025;317:e251598.
    

    >> Share

    
    October 2025
21. DENG M, Li Z, Sun L, Wang H, et al
    Liver MRI-derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study.
    Radiology. 2025;317:e250026.
    

    >> Share

    
    
22. FOWLKES JB
    Microbubbles, Ultrasound, and Radiation: Finding the Treatment Synergy for Hepatocellular Carcinoma.
    Radiology. 2025;317:e252815.
    

    >> Share

    
    September 2025
23. WESSNER CE, Forsberg F, Lyshchik A, O'Kane P, et al
    Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial.
    Radiology. 2025;316:e250083.
    

    >> Share

    
    August 2025
24. CANNELLA R
    MRI Quantitative Features: A Bridge to Hepatocellular Carcinoma Tumor Profiling.
    Radiology. 2025;316:e252216.
    

    >> Share

    
    
25. MATUSCHEWSKI NJ, Sobirey R, Revzin M, Zeevi T, et al
    Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2025;316:e242750.
    

    >> Share

    
    
26. XIA H, Min Y, Wang Y, Gao S, et al
    Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet-induced Mouse Model.
    Radiology. 2025;316:e243780.
    

    >> Share

    
    July 2025
27. ABEDRABBO N, Lam ET, McInnes MDF, Dawit H, et al
    Impact of LI-RADS CT and MRI Ancillary Features on Diagnostic Performance: An Individual Participant Data Meta-Analysis.
    Radiology. 2025;316:e242278.
    

    >> Share

    
    
28. LEWANDOWSKI RJ, Serhal M, Padia SA, Kim E, et al
    The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy.
    Radiology. 2025;316:e240333.
    

    >> Share

    
    
29. HUANG TY, Li ZY, Tian J, Xie XJ, et al
    Metabolic Dysfunction-Associated Steatotic Liver Disease at Quantitative US: International Prospective Study.
    Radiology. 2025;316:e242564.
    

    >> Share

    
    
30. ZHANG W, Shen G
    Hepatic Langerhans Cell Histiocytosis Revealed at FAPI PET/CT.
    Radiology. 2025;316:e243458.
    

    >> Share

    
    
31. REA B, Blakeborough A
    Case 339: Hepatobiliary Contrast Agent Uptake in an Adrenal Metastasis from Hepatocellular Carcinoma.
    Radiology. 2025;316:e242718.
    

    >> Share

    
    June 2025
32. ADAMO RG, van der Pol CB, Alabousi M, Lam E, et al
    Diagnostic Performance of CT/MRI LI-RADS Version 2018 Major Feature Combinations: Individual Participant Data Meta-Analysis.
    Radiology. 2025;315:e243450.
    

    >> Share

    
    May 2025
33. LIU H, Fan W, Li H, Qiao L, et al
    Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial.
    Radiology. 2025;315:e242315.
    

    >> Share

    
    April 2025
34. WU H, Zhu Z, Li J, Qiu C, et al
    Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression.
    Radiology. 2025;315:e242349.
    

    >> Share

    
    
35. QIU C
    US Markers for Differentiating Hepatic Inflammation in Chronic Liver Disease: Still a Long Way to Go.
    Radiology. 2025;315:e242559.
    

    >> Share

    
    
36. GUO X, Zhou Y
    Agenesis of the Intrahepatic Inferior Vena Cava with Pulmonary Venous Fistula.
    Radiology. 2025;315:e242069.
    

    >> Share

    
    March 2025
37. LEE S, Yoon JK, Shin J, Shin H, et al
    US Liver Imaging Reporting and Data System Version 2017: A Systematic Review and Meta-Analysis.
    Radiology. 2025;314:e240450.
    

    >> Share

    
    
38. DELL T, Mesropyan N, Layer Y, Tischler V, et al
    Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study.
    Radiology. 2025;314:e241677.
    

    >> Share

    
    
39. REA B, Blakeborough A
    Case 339.
    Radiology. 2025;314:e242717.
    

    >> Share

    
    
40. AN J, Park R, Kim E, Na SK, et al
    LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C.
    Radiology. 2025;314:e241856.
    

    >> Share

    
    
41. SCHOLLNAST H
    Imaging-based Hepatocellular Carcinoma Diagnosis: An Extension of LI-RADS to Patients with Noncirrhotic Hepatitis C.
    Radiology. 2025;314:e250627.
    

    >> Share

    
    February 2025
42. ZHANG YJ, Chen J, Zhou Z, Hu D, et al
    Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.
    Radiology. 2025;314:e241096.
    

    >> Share

    
    
43. ZHANG K, He K, Zhang L, Li WC, et al
    Gadoxetic Acid-enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma.
    Radiology. 2025;314:e233229.
    

    >> Share

    
    
44. RONOT M
    Advancing Care: Managing Small Late-Recurrence Hepatocellular Carcinoma with Image-guided Therapy.
    Radiology. 2025;314:e243768.
    

    >> Share

    
    
45. BITAR R, Salem R, Finn R, Greten TF, et al
    Erratum for: Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2025;314:e259004.
    

    >> Share

    
    January 2025
46. WILDMAN-TOBRINER B, Felice N, Kalisz KR, Allen BC, et al
    Photon-Counting CT Effects on Sensitivity for Liver Lesion Detection: A Reader Study Using Virtual Imaging.
    Radiology. 2025;314:e241568.
    

    >> Share

    
    
47. LYSHCHIK A, Kuon Yeng Escalante C, Siu Xiao T, Piscaglia F, et al
    Contrast-enhanced US of High-Risk Indeterminate Focal Liver Observations Categorized as LR-4 or LR-M at CT/MRI.
    Radiology. 2025;314:e240916.
    

    >> Share

    
    
48. LI W, Lv J, Li H, Song L, et al
    Quantification of Vascular Remodeling and Sinusoidal Capillarization to Assess Liver Fibrosis with Photoacoustic Imaging.
    Radiology. 2025;314:e241275.
    

    >> Share

    
    December 2024
49. KAMAYA A, Fetzer DT, Seow JH, Burrowes DP, et al
    LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of Radiology US LI-RADS.
    Radiology. 2024;313:e240169.
    

    >> Share

    
    
50. JANG HJ, Choi SH, Wee S, Choi SJ, et al
    CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma.
    Radiology. 2024;313:e240961.
    

    >> Share

    
    November 2024
51. HAGHSHOMAR M, Antonacci D, Smith AD, Thaker S, et al
    Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis.
    Radiology. 2024;313:e241171.
    

    >> Share

    
    
52. JIANG H, Cannella R, Wu Z, Beaufrere A, et al
    Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.
    Radiology. 2024;313:e233471.
    

    >> Share

    
    
53. HARMATH C
    Hepatocellular Carcinoma: The Meaning of Intratumoral Fat Patterns in Different Patient Populations.
    Radiology. 2024;313:e242740.
    

    >> Share

    
    
54. LAI B, Zhong J
    Hepatic Langerhans Cell Histiocytosis.
    Radiology. 2024;313:e241037.
    

    >> Share

    
    
55. ASLAM A, Chernyak V, Miller FH, Bashir M, et al
    CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.
    Radiology. 2024;313:e232408.
    

    >> Share

    
    
56. BITAR R, Salem R, Finn R, Greten TF, et al
    Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2024;313:e232875.
    

    >> Share

    
    October 2024
57. RIEDEL C, Hoffmann M, Ismahil M, Lenz A, et al
    Four-dimensional Flow MRI-based Computational Fluid Dynamics Simulation for Noninvasive Portosystemic Pressure Gradient Assessment in Patients with Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt.
    Radiology. 2024;313:e232989.
    

    >> Share

    
    
58. MATOS C, Metens T
    Liver Fibrosis: Diving into Microstructure with Diffusion-weighted Imaging.
    Radiology. 2024;313:e242548.
    

    >> Share

    
    
59. ZHANG L, Long X, Chen L, Han X, et al
    Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI.
    Radiology. 2024;313:e240343.
    

    >> Share

    
    
60. CAO J, Mroueh N, Mercaldo N, Lennartz S, et al
    Detectability of Hypoattenuating Liver Lesions with Deep Learning CT Reconstruction: A Phantom and Patient Study.
    Radiology. 2024;313:e232749.
    

    >> Share

    
    
61. MOTOSUGI U, Watanabe H
    Navigating Hemodynamic Insights: A Promising Future with Four-dimensional Flow MRI and Computational Fluid Dynamics in Transjugular Intrahepatic Portosystemic Shunt Management.
    Radiology. 2024;313:e241857.
    

    >> Share

    
    
62. FERRAIOLI G, Roccarina D, Barr RG
    Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis.
    Radiology. 2024;313:e240162.
    

    >> Share

    
    September 2024
63. MENDIRATTA-LALA M, Wiggermann P, Pech M, Serres-Creixams X, et al
    The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors.
    Radiology. 2024;312:e233051.
    

    >> Share

    
    
64. PIERCE TT, Ozturk A, Sherlock SP, Moura Cunha G, et al
    Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease.
    Radiology. 2024;312:e233094.
    

    >> Share

    
    
65. AHMED TM, Fishman EK
    Cinematic Rendering of Hepatic Hydatid Disease.
    Radiology. 2024;312:e240527.
    

    >> Share

    
    
66. WILDMAN-TOBRINER B
    Photon-counting Detector CT: A Promising Tool for Noninvasive Liver Fat Assessment.
    Radiology. 2024;312:e241963.
    

    >> Share

    
    
67. LIN H, Xu X, Deng R, Xu Z, et al
    Photon-counting Detector CT for Liver Fat Quantification: Validation across Protocols in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e240038.
    

    >> Share

    
    August 2024
68. SUGIMOTO K, Moriyasu F, Dioguardi Burgio M, Vilgrain V, et al
    US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study.
    Radiology. 2024;312:e233377.
    

    >> Share

    
    
69. YIN M
    Shear-Wave Dispersion for Detecting Hepatic Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e241420.
    

    >> Share

    
    
70. CHEUNG CL, Tripathi V, Chiang CL, Chiu KWH, et al
    Impact of Hepatocellular Carcinoma Etiology on the Performance of LI-RADS LR5.
    Radiology. 2024;312:e240056.
    

    >> Share

    
    June 2024
71. KIM PH, Hwang JY, Choi YH, Yoon HM, et al
    Safety of Gadoxetate Disodium for Hepatobiliary MRI in Children and Adolescents.
    Radiology. 2024;311:e232462.
    

    >> Share

    
    
72. OTERO HJ
    Gadoxetate Disodium Hepatobiliary Contrast Material Is Safe in Children and Adolescents.
    Radiology. 2024;311:e241082.
    

    >> Share

    
    May 2024
73. SARWAR A, Malik MS, Vo NH, Tsai LL, et al
    Efficacy and Safety of Radiation Segmentectomy with (90)Y Resin Microspheres for Hepatocellular Carcinoma.
    Radiology. 2024;311:e231386.
    

    >> Share

    
    
74. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    

    >> Share

    
    
75. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    

    >> Share

    
    
76. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.
    

    >> Share

    
    
77. MILOT L
    Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e240124.
    

    >> Share

    
    
78. LYSHCHIK A, Fetzer DT, Kono Y, Wilson SR, et al
    Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e232369.
    

    >> Share

    
    April 2024
79. YOON JH, Kim YK, Kim JW, Chang W, et al
    Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
    Radiology. 2024;311:e233114.
    

    >> Share

    
    
80. LEE Y, Kim NH, Kang JH, Cho YS, et al
    Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
    Radiology. 2024;311:e232188.
    

    >> Share

    
    
81. LYU L, Xu P
    Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
    Radiology. 2024;311:e232426.
    

    >> Share

    
    
82. GHOSH A
    B-mode US and Deep Learning Rivals Shear-Wave Elastography in Screening for Fibrosis.
    Radiology. 2024;311:e240868.
    

    >> Share

    
    
83. ZENG QQ, Liang P
    Super-Resolution US Imaging of Focal Nodular Hyperplasia.
    Radiology. 2024;311:e233130.
    

    >> Share

    
    
84. CHEN LD, Huang ZR, Yang H, Cheng MQ, et al
    US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening.
    Radiology. 2024;311:e231461.
    

    >> Share

    
    March 2024
85. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
    Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
    Radiology. 2024;310:e231220.
    

    >> Share

    
    
86. LIU F, Bi M, Jing X, Ding H, et al
    Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
    Radiology. 2024;310:e232416.
    

    >> Share

    
    
87. REUTER KL
    Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
    Radiology. 2024;310:e240436.
    

    >> Share

    
    February 2024
88. CHAPIRO J
    Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool.
    Radiology. 2024;310:e240072.
    

    >> Share

    
    
89. AUER TA, Muller L, Schulze D, Anhamm M, et al
    CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
    Radiology. 2024;310:e232044.
    

    >> Share

    
    
90. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
    Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
    Radiology. 2024;310:e232365.
    

    >> Share

    
    
91. GEMMETE JJ
    Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
    Radiology. 2024;310:e240015.
    

    >> Share

    
    
92. CRIVELLARO P
    A Deeper Look into Ancillary Features in LI-RADS Classification.
    Radiology. 2024;310:e240251.
    

    >> Share

    
    
93. DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
    LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
    Radiology. 2024;310:e231501.
    

    >> Share

    
    
94. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
    Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Radiology. 2024;310:e231160.
    

    >> Share

    
    
95. KARTALIS N, Grigoriadis A
    LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
    Radiology. 2024;310:e240161.
    

    >> Share

    
    January 2024
96. MA L, Zhang W, Ma J, Luo J, et al
    Transjugular Intrahepatic Portosystemic Shunt versus Endoscopy with Drug Therapy Warrants Further Exploration.
    Radiology. 2024;310:e232499.
    

    >> Share

    
    
97. TAN XZ, Chen X, Liu P
    Potential Influence of Inconsistent Arterial Phase Imaging on Macrotrabecular-massive Hepatocellular Carcinoma Prediction.
    Radiology. 2024;310:e232349.
    

    >> Share

    
    
98. KADI D, Loomba R, Bashir MR
    Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
    Radiology. 2024;310:e222695.
    

    >> Share

    
    
99. FOWLER KJ, Chernyak V
    What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease.
    Radiology. 2024;310:e232771.
    

    >> Share

    
    
100. DIETRICH CF
     Modified Algorithm for Contrast-enhanced US LI-RADS.
     Radiology. 2024;310:e232742.
     

     >> Share

     
     December 2023
101. GOINS SM, Jiang H, van der Pol CB, Salameh JP, et al
     Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
     Radiology. 2023;309:e231656.
     

     >> Share

     
     
102. SIRLIN CB, Chernyak V
     Are We Ready to Simplify and Improve LI-RADS?
     Radiology. 2023;309:e233164.
     

     >> Share

     
     
103. TAMIR S, Tau N
     Hepatocellular Carcinoma and Pretransplant Liver Imaging: Benefits of Per-patient Assessment.
     Radiology. 2023;309:e233123.
     

     >> Share

     
     
104. HASSAN OT, Behr SC, Ohliger MA, Fowler KJ, et al
     Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
     Radiology. 2023;309:e222776.
     

     >> Share

     
     November 2023
105. JIANG H, Yang C, Chen Y, Wang Y, et al
     Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
     Radiology. 2023;309:e230527.
     

     >> Share

     
     
106. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
     Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
     Radiology. 2023;309:e222891.
     

     >> Share

     
     
107. TSAI R, Mellnick VM
     Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
     Radiology. 2023;309:e232480.
     

     >> Share

     
     
108. OZTURK A, Kumar V, Pierce TT, Li Q, et al
     The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
     Radiology. 2023;309:e223146.
     

     >> Share

     
     
109. TAN XZ, Liu P, Xiang H
     The Influence of Single Arterial Phase Imaging on Prediction of Microvascular Invasion of Hepatocellular Carcinoma.
     Radiology. 2023;309:e231141.
     

     >> Share

     
     October 2023
110. TUTHILL TA
     Advancing AI-assisted US Screening for Fatty Liver.
     Radiology. 2023;309:e232442.
     

     >> Share

     
     
111. HAN A
     Hepatic Steatosis Assessment: Harnessing the Power of Integrating Multiple Quantitative US Parameters.
     Radiology. 2023;309:e232475.
     

     >> Share

     
     
112. VIANNA P, Calce SI, Boustros P, Larocque-Rigney C, et al
     Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
     Radiology. 2023;309:e230659.
     

     >> Share

     
     
113. KURODA H, Oguri T, Kamiyama N, Toyoda H, et al
     Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
     Radiology. 2023;309:e230341.
     

     >> Share

     
     
114. SAVSANI E, Shaw CM, Forsberg F, Wessner CE, et al
     Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
     Radiology. 2023;309:e230727.
     

     >> Share

     
     
115. HEO S, Lee SS, Choi SH, Kim DW, et al
     CT Rule-in and Rule-out Criteria for Clinically Significant Portal Hypertension in Chronic Liver Disease.
     Radiology. 2023;309:e231208.
     

     >> Share

     
     
116. FRAUM TJ
     CT-based Diagnosis of Clinically Significant Portal Hypertension: An Opportunity to Prevent Complications.
     Radiology. 2023;309:e232439.
     

     >> Share

     
     
117. XIA T, Du M, Li H, Wang Y, et al
     Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
     Radiology. 2023;309:e231007.
     

     >> Share

     
     
118. REEDER SB, Starekova J
     MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation.
     Radiology. 2023;309:e232552.
     

     >> Share

     
     
119. MONSELL SE
     Statistical Methods for Exploring Causal Relationships between Risk Factors and Liver Disease.
     Radiology. 2023;309:e232551.
     

     >> Share

     
     
120. FOWLER KJ, Venkatesh SK, Obuchowski N, Middleton MS, et al
     Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
     Radiology. 2023;309:e231092.
     

     >> Share

     
     
121. KOZAKA K, Matsui O
     MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease.
     Radiology. 2023;309:e232420.
     

     >> Share

     
     September 2023
122. HYODO R, Takehara Y, Mizuno T, Ichikawa K, et al
     Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization.
     Radiology. 2023;308:e230709.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share